Significant Ownership of 3i, LP

Large-stake snapshot 1 fact
Schedule 13D/G summary
  • Recent SEC Schedule 13D/G filings for 3i, LP focus on large-stake beneficial ownership disclosures and amendments.
  • Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
Manager identity 2 facts
Signature and title
/s/ Maier Joshua Tarlow - Maier Joshua Tarlow, Manager of 3i Management LLC, General Partner of 3i, LP
Location
Dover, DE

Follow Filing Activity

Follow 3i, LP and return when a new Schedule 13D/G filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Significant Ownership of 3i, LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PTHS Pelthos Therapeutics Inc. Common Stock, par value $0.0001 per share 9.9% $7,751,598 +$417,220 337,026 +5.7% 3i, LP 31 Mar 2026
CNBX CNBX Pharmaceuticals Inc. Common Stock, par value $0.0001 per share 9.9% $1,249,464 +$413,508 124,946,375 +49% 3i, LP 31 Mar 2026
SCPX Scorpius Holdings, Inc. Common Stock, par value $0.0002 per share 9.9% $678,609 6,786,087 0% 3i, LP 31 Dec 2025
TIVC Valion Bio, Inc. Common Stock, par value $0.0001 per share 9.9% $310,601 +$31,652 307,526 +11% 3i, LP 31 Mar 2026
ZSPC zSpace, Inc. Common Stock, par value $0.00001 per share 9.9% $38,160 336,211 3i, LP 21 Apr 2026
NCPL Netcapital Inc. Common Stock, par value $0.001 per share 6.1% $197,315 -$5,052 505,935 -2.5% 3i, LP 31 Mar 2026
BCTX BriaCell Therapeutics Corp. Common Shares, no par value 4.9% $872,128 -$821,582 190,006 -49% 3i, LP 31 Mar 2025
PCSA Processa Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share 4.9% $504,583 1,681,944 3i, LP 17 Jun 2025
TWG Top Wealth Group Holding Ltd Class A Ordinary Shares, par value $0.009 per share 4.9% $368,018 68,278 3i, LP 10 Dec 2025
XPON Expion360 Inc. Common Stock, par value $0.001 per share 4.9% $102,381 110,087 3i, LP 31 Dec 2024
KWE KWESST Micro Systems Inc. Common Shares, no par value 4.9% $70,679 353,393 3i, LP 31 Dec 2024
VINOQ Gaucho Group Holdings, Inc. Common Stock, par value $0.01 per share 4.5% $4,446 -$5,305 44,463 -54% 3i, LP 30 Jun 2025
HUSA Houston American Energy Corp. Common Stock, par value $0.001 per share 2% $190,391 -$589,609 317,318 -76% 3i, LP 31 Mar 2025
HUSA Houston American Energy Corp. Common Stock, par value $0.001 per share 1.9% $7,857,354 653,690 3i Management LLC 20 Jun 2025
LITM Snow Lake Resources Ltd. Common Shares, no par value 1.1% $365,651 -$1,779,349 831,026 -83% 3i, LP 31 Dec 2024
VMAR Vision Marine Technologies Inc. Common Shares, no par value per share 1.1% $227,600 40,000 3i, LP 18 Aug 2025
EEIQ EpicQuest Education Group International Limited Common Shares, par value $0.0016 per share 0.8% $115,583 180,599 3i, LP 26 Aug 2025
BIVI BioVie Inc. Class A Common Stock, $0.0001 par value per share 0% $0 0 3i, LP 31 Dec 2024
VEEE Twin Vee PowerCats Co. Common Stock, par value $0.001 per share 0% $0 -$434,000 0 -100% 3i, LP 30 Jun 2025

Schedules 13D/G Reported by 3i, LP:

Sym Target Class Ownership Change Current shares Change Value Reporting name Form Report period Filing date
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .